APA (7th ed.) Citation

Ziwen Lu, Zhixin Wang, Zhigang Tu, & Hanqing Liu. (2022). HSP90 Inhibitor Ganetespib Enhances the Sensitivity of Mantle Cell Lymphoma to Bruton's Tyrosine Kinase Inhibitor Ibrutinib. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Ziwen Lu, Zhixin Wang, Zhigang Tu, and Hanqing Liu. HSP90 Inhibitor Ganetespib Enhances the Sensitivity of Mantle Cell Lymphoma to Bruton's Tyrosine Kinase Inhibitor Ibrutinib. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Ziwen Lu, et al. HSP90 Inhibitor Ganetespib Enhances the Sensitivity of Mantle Cell Lymphoma to Bruton's Tyrosine Kinase Inhibitor Ibrutinib. Frontiers Media S.A., 2022.